Pharmacy World & Science

, Volume 32, Issue 2, pp 112–113 | Cite as

Gastric ulcer in a child treated with deferasirox

  • Tiene BautersEmail author
  • Veerle Mondelaers
  • Hugo Robays
  • Kathleen Hunninck
  • Barbara de Moerloose
Case Report


We present a patient with thalassemia major who developed a gastric ulcer, probably related to the use of deferasirox. Although gastric ulcer is mentioned as infrequent adverse event in the scientific product information of deferasirox, in our current knowledge, this is the first case-report on this adverse drug reaction. The severity of this event justifies the reporting of this case.


Case report Deferasirox Gastric ulcer Haematemesis Pediatrics Haemato-oncology 


Conflicts of interest

The authors have no conflicts of interest.


  1. 1.
    Stumpf J. Deferasirox. Am J Health Syst Pharm. 2007;64:606–16.CrossRefPubMedGoogle Scholar
  2. 2.
    Cappellini M. Long-term efficacy and safety of deferasirox. Blood Rev. 2008;22(S2):S35–41.CrossRefPubMedGoogle Scholar
  3. 3.
    Raphael JL, Bernhardt MB, Mahoney DH, Mueller BU. Oral iron chelation and the treatment of iron overload in a pediatric hematology center. Pediatr Blood Cancer. 2009;52(5):616–20.CrossRefPubMedGoogle Scholar
  4. 4.
    Vanorden HE, Hagemann TM. Deferasirox. An oral agent for chronic iron overload. Ann Pharmacother. 2006;40(6):1110–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006;107(9):3455–62.Google Scholar
  6. 6.
    Galanello R, Piga A, Forni GL, Bertrand Y, Foschini ML, Bordone E, et al. Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major. Haematologica. 2006;91(10):1343–51.PubMedGoogle Scholar
  7. 7.
    Scientific Leaflet Deferasirox (in Flemish). Accessed 3 August 2009.
  8. 8.
    Scientific Leaflet Folic Acid (in Flemish). Accessed 3 August 2009.
  9. 9.
    Identifying Adverse Drug Reactions. Accessed 14 April 2009.
  10. 10.
    Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Tiene Bauters
    • 1
    Email author
  • Veerle Mondelaers
    • 2
  • Hugo Robays
    • 1
  • Kathleen Hunninck
    • 2
  • Barbara de Moerloose
    • 2
  1. 1.Department of PharmacyGhent University HospitalGhentBelgium
  2. 2.Department of Pediatric Hemato-OncologyGhent University HospitalGhentBelgium

Personalised recommendations